Hims & Hers Health Inc (HIMS)

In the past 90 days, Hims & Hers Health Inc. has seen 55 insider trading transactions, with a total net value of approximately -$2.36 million, primarily driven by significant planned sales from executives, including CEO Andrew Dudum. Notably, on June 17, 2025, Dudum executed multiple planned sales totaling over $3.9 million. The company's stock has experienced a substantial price increase of 80.2% over the same period, following a strong earnings report where EPS exceeded expectations by 66.67%.

Track

Stock chart
Ticker: HIMS Exchange: NYS


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Earnings
 
Value bought

Past 90 days

 
Value sold

Past 90 days

 
Net insiders buying

Past 90 days

 
Trades (buy and sell)

Past 90 days

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-06-17 2025-06-17 PS Planned sale

Chi Michael

Chief Commercial Officer

Officer
1,000 -5.8%
59.75
USD 1,021,845 		1,000 -5.8% 59.75 USD 100,000
2025-06-17 2025-06-17 PS Planned sale

Dudum Andrew

Chief Executive Officer

Executive Director Large shareholder
1,000 -34.1%
59.45
USD 2,922,707 		1,000 -34.1% 59.45 USD 100,000
2025-06-17 2025-06-17 PS Planned sale

Dudum Andrew

Chief Executive Officer

Executive Director Large shareholder
1,000 -10.0%
58.50
USD 932,835 		1,000 -10.0% 58.50 USD 100,000
2025-06-17 2025-06-17 PS Planned sale

Becklund Irene

PAO

Officer
1,000 -92.3%
59.75
USD 506,979 		1,000 -92.3% 59.75 USD 100,000
2025-06-17 2025-06-17 PS Planned sale

Boughton Soleil

Chief Legal Officer

Officer
1,000 -1.6%
59.75
USD 153,677 		1,000 -1.6% 59.75 USD 100,000
2025-06-17 2025-06-16 PS Planned sale

Dudum Andrew

Chief Executive Officer

Executive Director Large shareholder
1,000 -10.0%
56.92
USD 1,008,012 		1,000 -10.0% 56.92 USD 100,000
2025-06-17 2025-06-16 PS Planned sale

Dudum Andrew

Chief Executive Officer

Executive Director Large shareholder
1,000 -33.7%
56.39
USD 5,110,197 		1,000 -33.7% 56.39 USD 100,000
2025-06-17 2025-06-16 PS Planned sale

Dudum Andrew

Chief Executive Officer

Executive Director Large shareholder
1,000 -6.0%
58.61
USD 996,405 		1,000 -6.0% 58.61 USD 100,000
2025-06-17 2025-06-16 PS Planned sale

Dudum Andrew

Chief Executive Officer

Executive Director Large shareholder
1,000 -3.0%
56.90
USD 421,871 		1,000 -3.0% 56.90 USD 100,000
2025-06-17 2025-06-16 PS Planned sale

Dudum Andrew

Chief Executive Officer

Executive Director Large shareholder
1,000 -14.1%
56.44
USD 2,264,429 		1,000 -14.1% 56.44 USD 100,000
2025-06-17 2025-06-16 PS Planned sale

Dudum Andrew

Chief Executive Officer

Executive Director Large shareholder
1,000 -1.7%
56.35
USD 157,336 		1,000 -1.7% 56.35 USD 100,000
2025-06-17 2025-06-16 PS Planned sale

Boughton Soleil

Chief Legal Officer

Officer
1,000 -3.2%
56.80
USD 309,617 		1,000 -3.2% 56.80 USD 100,000
2025-06-11 2025-06-10 PS Planned sale

Chi Michael

Chief Commercial Officer

Officer
1,000 -2.1%
57.00
USD 319,200 		1,000 -2.1% 57.00 USD 100,000
2025-06-09 2025-06-06 PS Planned sale

Chi Michael

Chief Commercial Officer

Officer
1,000 -1.4%
56.00
USD 201,600 		1,000 -1.4% 56.00 USD 100,000
2025-06-09 2025-06-06 PS Planned sale

Chi Michael

Chief Commercial Officer

Officer
1,000 -0.6%
56.00
USD 84,000 		1,000 -0.6% 56.00 USD 100,000
2025-05-30 2025-05-28 PS Planned sale

Okupe Oluyemi

Chief Financial Officer

Officer
11,581 -22.8%
52.98
USD 613,537 		11,581 -22.8% 52.98 USD 613,537
2025-05-29 2025-05-27 PS Planned sale

Boughton Soleil

Chief Legal Officer

Officer
3,233 -2.1%
55.87
USD 180,628 		3,233 -2.1% 55.87 USD 180,628
2025-05-27 2025-05-22 PS Planned sale

Becklund Irene

PAO

Officer
5,071 -100.0%
53.51
USD 271,349 		5,071 -100.0% 53.51 USD 271,349
2025-05-19 2025-05-16 PS Planned sale

Dudum Andrew

Chief Executive Officer

Executive Director Large shareholder
6,427 -6.7%
59.21
USD 380,535 		6,427 -6.7% 59.21 USD 380,535
2025-05-19 2025-05-16 PS Planned sale

Dudum Andrew

Chief Executive Officer

Executive Director Large shareholder
52,642 -35.5%
58.67
USD 3,088,501 		52,642 -35.5% 58.67 USD 3,088,501
// ... existing code ...